肺癌是目前发病率和死亡率最高的恶性肿瘤,其治疗是人们关注的焦点。接近80.0%的肺癌患者确诊时已属晚期,大多数患者需要接受全身治疗。传统的化疗和放疗缺乏特异性,在取得疗效的同时也给患者带来较大的不良反应。虽然近些年化疗疗效已经取得一定进展,但晚期肺癌患者仍难以长期生存。选择肺癌细胞特异的分子靶点,应用针对该靶点的药物进行治疗,在取得明显疗效的同时,又避免对正常细胞的 Lung cancer is currently the highest incidence and mortality of malignant tumors, the treatment is the focus of attention. Nearly 80.0% of lung cancer patients have been diagnosed late, most patients need systemic treatment. The lack of specificity of traditional chemotherapy and radiotherapy, but also to patients with greater adverse reactions. Although chemotherapy has made some progress in recent years, patients with advanced lung cancer still have difficulty in long-term survival. Select lung cancer cell-specific molecular targets, the application of targeted drugs for treatment, while achieving significant efficacy, while avoiding the normal cells